BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20564139)

  • 21. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.
    Boers A; Wang R; van Leeuwen RW; Klip HG; de Bock GH; Hollema H; van Criekinge W; de Meyer T; Denil S; van der Zee AGJ; Schuuring E; Wisman GBA
    Clin Epigenetics; 2016; 8():29. PubMed ID: 26962367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysis.
    Kelly H; Benavente Y; Pavon MA; De Sanjose S; Mayaud P; Lorincz AT
    Br J Cancer; 2019 Nov; 121(11):954-965. PubMed ID: 31616037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylated ZNF582 gene as a marker for triage of women with Pap smear reporting low-grade squamous intraepithelial lesions - a Taiwanese Gynecologic Oncology Group (TGOG) study.
    Lin H; Chen TC; Chang TC; Cheng YM; Chen CH; Chu TY; Hsu ST; Liu CB; Yeh LS; Wen KC; Huang CY; Yu MH
    Gynecol Oncol; 2014 Oct; 135(1):64-8. PubMed ID: 25134998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear results.
    Lin CJ; Lai HC; Wang KH; Hsiung CA; Liu HW; Ding DC; Hsieh CY; Chu TY
    Am J Obstet Gynecol; 2011 Jan; 204(1):21.e1-7. PubMed ID: 20833385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort.
    van Leeuwen RW; Oštrbenk A; Poljak M; van der Zee AGJ; Schuuring E; Wisman GBA
    Int J Cancer; 2019 Feb; 144(4):746-754. PubMed ID: 30259973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests.
    Kahn SL; Ronnett BM; Gravitt PE; Gustafson KS
    Cancer; 2008 Feb; 114(1):57-64. PubMed ID: 18181097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real time quantitative methylation detection of PAX1 gene in cervical cancer screening.
    Liu H; Meng X; Wang J
    Int J Gynecol Cancer; 2020 Oct; 30(10):1488-1492. PubMed ID: 32616628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA methylation analysis in liquid-based cytology for cervical cancer screening.
    Apostolidou S; Hadwin R; Burnell M; Jones A; Baff D; Pyndiah N; Mould T; Jacobs IJ; Beddows S; Kocjan G; Widschwendter M
    Int J Cancer; 2009 Dec; 125(12):2995-3002. PubMed ID: 19609949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens.
    Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Kweon SS; Fackler MJ; Sukumar S
    Virchows Arch; 2010 Jul; 457(1):35-42. PubMed ID: 20496080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma.
    Wang R; van Leeuwen RW; Boers A; Klip HG; de Meyer T; Steenbergen RD; van Criekinge W; van der Zee AG; Schuuring E; Wisman GB
    Oncotarget; 2016 Dec; 7(49):80735-80750. PubMed ID: 27738327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The application value of PAX1 and ZNF582 gene methylation in high grade intraepithelial lesion and cervical cancer.
    Liang H; Li GL; Liu J; Fu M; Huang H; Zhao K; Wei Y; Xiao J
    Clin Transl Oncol; 2021 Feb; 23(2):283-288. PubMed ID: 32514824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PAX1 and SOX1 methylation as an initial screening method for cervical cancer: a meta-analysis of individual studies in Asians.
    Chen Y; Cui Z; Xiao Z; Hu M; Jiang C; Lin Y; Chen Y
    Ann Transl Med; 2016 Oct; 4(19):365. PubMed ID: 27826568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of DNA methylation of SOX9 in cervical cancer using methylated-CpG island recovery assay.
    Wu JH; Liang XA; Wu YM; Li FS; Dai YM
    Oncol Rep; 2013 Jan; 29(1):125-32. PubMed ID: 23064448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
    Chang CL; Ho SC; Su YF; Juan YC; Huang CY; Chao AS; Hsu ZS; Chang CF; Fwu CW; Chang TC
    Gynecol Oncol; 2021 May; 161(2):429-435. PubMed ID: 33757653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. JAM3 methylation status as a biomarker for diagnosis of preneoplastic and neoplastic lesions of the cervix.
    Yin A; Zhang Q; Kong X; Jia L; Yang Z; Meng L; Li L; Wang X; Qiao Y; Lu N; Yang Q; Shen K; Kong B
    Oncotarget; 2015 Dec; 6(42):44373-87. PubMed ID: 26517242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective study on the predictive value of DNA methylation in cervical intraepithelial neoplasia prognosis.
    Guo Z; Hu Y; Yuan L; Li N; Wang T
    Arch Gynecol Obstet; 2018 Sep; 298(3):589-596. PubMed ID: 29971561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylated
    Su Y; Tang Y; Zhang T; Xu Y; Zhang Y; Shen Y; Qin L; Zhang L; Cao L; Zhou Y; Liou Y; Zhang M
    Future Oncol; 2022 Jul; 18(23):2583-2592. PubMed ID: 35758002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women.
    Vasiljević N; Scibior-Bentkowska D; Brentnall AR; Cuzick J; Lorincz AT
    Gynecol Oncol; 2014 Mar; 132(3):709-14. PubMed ID: 24508839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women: Results from a Dutch primary HPV-based screening cohort.
    Verhoef L; Bleeker MCG; Polman N; Steenbergen RDM; Meijer CJLM; Melchers WJG; Bekkers RL; Molijn AC; Quint WG; van Kemenade FJ; Berkhof J; Heideman DAM
    Int J Cancer; 2022 Feb; 150(3):440-449. PubMed ID: 34558659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients.
    Eijsink JJ; Lendvai Á; Deregowski V; Klip HG; Verpooten G; Dehaspe L; de Bock GH; Hollema H; van Criekinge W; Schuuring E; van der Zee AG; Wisman GB
    Int J Cancer; 2012 Apr; 130(8):1861-9. PubMed ID: 21796628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.